Drug Repurposing: An Alternative Strategy to Treat COVID-19

被引：0
|
作者：
Han, Pengyu [1 ,2 ]
Zheng, Huifang [1 ]
Wen, Pingping [3 ]
Pan, Li [3 ]
Geng, Dan [3 ]
Sun, Dianxing [1 ]
机构：
[1] 980th Hosp PLA Joint Logist Force, Dept Infect Dis, Shijiazhuang 050082, Hebei, Peoples R China
[2] Dandong Customs House, Dandong, Peoples R China
[3] Dept Technol, Dalian, Peoples R China
来源：
CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 2022年 / 23卷 / 06期
基金：
中国国家自然科学基金;
关键词：
COVID-19; SARS-CoV-2; immuno-regulation; risk factor; pH; Anti-viral agents; surfactants; PROLIFERATOR-ACTIVATED RECEPTORS; N-ACETYL-CYSTEINE; INSULIN-RESISTANCE; HOST-DEFENSE; ZINC IONS; SARS-COV; T-CELLS; VIRUS; INFLAMMATION; DIETHYLCARBAMAZINE;
D O I：
10.2174/1389201022666210709141320
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In order to curve the ongoing trend of the COVID-19 pandemic and save more lives, effective treatments against COVID-19 are urgently needed. Compared to developing new drugs, which may take too much time, it's more efficient and cost-effective to repurpose existing drugs in the treatment of COVID-19. Fortunately, some of the shared features of COVID-19 and other wellknown diseases make it possible to use old strategies to combat this new challenge. In this paper, we reviewed various possible strategies of drug repurposing in the treatment of COVID-19 and explored the possible scientific mechanisms behind each strategy.
引用
收藏
页码：818 / 827
页数：10
相关论文
共 50 条
  • [1] An Omics Strategy for Translational Bioinformatics and Rapid COVID-19 Drug Repurposing
    Revikumar, Amjesh
    [J]. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2023, 27 (03) : 109 - 115
  • [2] Drug Repurposing in the Treatment of COVID-19
    Soylu, Mehmet
    Ozbek, Emine Nur
    Yetik Anacak, Gunay
    [J]. BEZMIALEM SCIENCE, 2020, 8 : 84 - 93
  • [3] COVID-19 and the Drug Repurposing Tsunami
    Mucke, Hermann A. M.
    [J]. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2020, 18 (05) : 211 - 214
  • [4] Drug repurposing for the treatment of COVID-19
    Kato, Yuri
    Nishiyama, Kazuhiro
    Nishimura, Akiyuki
    Noda, Takamasa
    Okabe, Kaori
    Kusakabe, Takahiro
    Kanda, Yasunari
    Nishida, Motohiro
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2022, 149 (03) : 108 - 114
  • [5] Repurposing chlorpromazine to treat COVID-19: The reCoVery study
    Plaze, M.
    Attali, D.
    Petit, A-C
    Blatzer, M.
    Simon-Loriere, E.
    Vinckier, F.
    Cachia, A.
    Chretien, F.
    Gaillard, R.
    [J]. ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2020, 46 (03): : 169 - 172
  • [6] Population-Based Drug Repurposing to Treat Thrombosis in COVID-19 Patients.
    Kim, Yejin
    Chen, Luyao
    Jiang, Xiaoqian
    Savitz, Sean, I
    [J]. STROKE, 2021, 52
  • [7] A Rapid Strategy for Repurposing Drugs for COVID-19
    Khoubnasabjafari, Maryam
    Amanlou, Massoud
    Dehpour, Ahmad Reza
    Jouyban, Abolghasem
    [J]. PHARMACEUTICAL SCIENCES, 2020, 26 : S91 - S93
  • [8] Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19
    Stolfi, Paola
    Manni, Luigi
    Soligo, Marzia
    Vergni, Davide
    Tieri, Paolo
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [9] Editorial: Drug Repurposing for COVID-19 Therapy
    Maldonado, Rafael
    Drago, Filippo
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [10] A review on drug repurposing applicable to COVID-19
    Dotolo, Serena
    Marabotti, Anna
    Facchiano, Angelo
    Tagliaferri, Roberto
    [J]. BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 726 - 741
12345